Aggregated
No track record data- Bullish
- 9
- Hold
- 0
- Bearish
- 0
Needham
A Needham analyst with 180 tracked ratings across 43 distinct tickers maintains a 4.7 out of 5 stars track record, having issued 130 bullish ratings and 20 holds, while also covering multiple sources.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| OCS | 2026-06-01 | buy | $38.00 | Aggregated |
| TRVI | 2026-05-20 | buy | $23.00 | Aggregated |
| MLTX | 2026-05-12 | buy | $30.00 | Aggregated |
| OCS | 2026-05-12 | buy | $46.00 | Aggregated |
| LQDA | 2026-05-11 | buy | $70.00 | Aggregated |
| AMPH | 2026-05-08 | hold | - | Aggregated |
| XENE | 2026-05-08 | buy | $78.00 | Aggregated |
| ARQT | 2026-05-07 | buy | $36.00 | Aggregated |
| NAMS | 2026-05-07 | buy | $48.00 | Aggregated |
| BCRX | 2026-05-06 | buy | $16.00 | Aggregated |
| CYTK | 2026-05-06 | buy | $102.00 | Aggregated |
| TRVI | 2026-05-06 | buy | $23.00 | Aggregated |
| CYTK | 2026-05-05 | buy | $102.00 | Aggregated |
| OCUL | 2026-05-05 | buy | $18.00 | Aggregated |
| VRDN | 2026-05-05 | buy | $32.00 | Aggregated |
| ESPR | 2026-05-04 | hold | - | Aggregated |
| PCRX | 2026-05-01 | buy | $32.00 | Aggregated |
| KALV | 2026-04-30 | hold | - | Aggregated |
| CRMD | 2026-04-27 | buy | $15.00 | Aggregated |
| VRDN | 2026-03-30 | buy | $32.00 | Aggregated |
| KALV | 2026-03-25 | buy | $36.00 | Aggregated |
| COLL | 2026-03-19 | buy | $56.00 | Aggregated |
| TRVI | 2026-03-18 | buy | $24.00 | Aggregated |
| XENE | 2026-03-09 | buy | $80.00 | Aggregated |
| CRMD | 2026-03-05 | buy | $14.00 | Aggregated |
| LQDA | 2026-03-05 | buy | $54.00 | Aggregated |
| ESPR | 2026-03-03 | buy | $5.00 | Aggregated |
| XENE | 2026-02-27 | buy | $58.00 | Aggregated |
| ARQT | 2026-02-26 | buy | $36.00 | Aggregated |
| COLL | 2026-02-26 | buy | $54.00 | Aggregated |
| MLTX | 2026-02-26 | buy | $25.00 | Aggregated |
| CYTK | 2026-02-25 | buy | $85.00 | Aggregated |
| LQDA | 2026-02-25 | buy | $52.00 | Aggregated |
| MLTX | 2026-02-23 | buy | $25.00 | Aggregated |
| OCUL | 2026-02-20 | buy | $18.00 | Aggregated |
| NAMS | 2026-02-18 | buy | $48.00 | Aggregated |
| VRDN | 2026-02-04 | buy | $42.00 | Aggregated |
| ARQT | 2026-01-26 | buy | $31.00 | Aggregated |
| KALV | 2026-01-09 | buy | $35.00 | Aggregated |
| PCRX | 2026-01-09 | buy | $30.00 | Aggregated |
| COLL | 2026-01-08 | buy | $56.00 | Aggregated |
| CRMD | 2026-01-08 | buy | $15.00 | Aggregated |
| KALV | 2026-01-06 | buy | $32.00 | Aggregated |
| EOLS | 2025-12-24 | hold | - | Aggregated |
| VRDN | 2025-12-23 | buy | $42.00 | Aggregated |
| CYTK | 2025-12-22 | buy | $84.00 | Aggregated |
| CYTK | 2025-12-12 | buy | $72.00 | Aggregated |
| OCUL | 2025-12-08 | buy | $20.00 | Aggregated |
| KALV | 2025-12-04 | buy | $28.00 | Aggregated |
| CRMD | 2025-11-12 | buy | $16.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| OCS | 4 | 2026-06-01 | Aggregated |
| TRVI | 7 | 2026-05-20 | Aggregated |
| MLTX | 4 | 2026-05-12 | Aggregated |
| LQDA | 10 | 2026-05-11 | Aggregated |
| AMPH | 1 | 2026-05-08 | Aggregated |
| XENE | 5 | 2026-05-08 | Aggregated |
| ARQT | 11 | 2026-05-07 | Aggregated |
| NAMS | 2 | 2026-05-07 | Aggregated |
| BCRX | 9 | 2026-05-06 | Aggregated |
| CYTK | 5 | 2026-05-06 | Aggregated |
| OCUL | 8 | 2026-05-05 | Aggregated |
| VRDN | 7 | 2026-05-05 | Aggregated |
| ESPR | 6 | 2026-05-04 | Aggregated |
| PCRX | 9 | 2026-05-01 | Aggregated |
| KALV | 11 | 2026-04-30 | Aggregated |
| CRMD | 8 | 2026-04-27 | Aggregated |
| COLL | 10 | 2026-03-19 | Aggregated |
| EOLS | 7 | 2025-12-24 | Aggregated |
| CRMDCORMEDIX INC | 1 | 2025-11-12 | Aggregated |
| OCSOCULIS HOLDING AG | 1 | 2025-11-11 | Aggregated |
| NAMSNEWAMSTERDAM PHARMA COMPANY NV | 1 | 2025-11-05 | Aggregated |
| BCRXBIOCRYST PHARMACEUTICALS INC. | 1 | 2025-11-04 | Aggregated |
| LQDALIQUIDIA CORP | 1 | 2025-11-04 | Aggregated |
| XENEXENON PHARMACEUTICALS INC | 1 | 2025-11-04 | Aggregated |
| ARQTARCUTIS BIOTHERAPEUTICS INC | 1 | 2025-10-28 | Aggregated |
| COLLCOLLEGIUM PHARMACEUTICAL INC | 1 | 2025-10-28 | Aggregated |
| AMPHAMPHASTAR PHARMACEUTICALS INC | 1 | 2025-10-22 | Aggregated |
| OMER | 5 | 2025-10-15 | Aggregated |
| OCULOCULAR THERAPEUTIX INC | 1 | 2025-10-01 | Aggregated |
| MLTXMOONLAKE IMMUNOTHERAPEUTICS - ORDINARY SHARES - CLASS A | 1 | 2025-09-30 | Aggregated |
| KALVKALVISTA PHARMACEUTICALS INC | 1 | 2025-09-12 | Aggregated |
| CYTKCYTOKINETICS INC | 1 | 2025-09-02 | Aggregated |
| HRTX | 19 | 2025-08-08 | Aggregated |
| EOLSEVOLUS INC | 1 | 2025-08-06 | Aggregated |
| VRDNVIRIDIAN THERAPEUTICS INC | 1 | 2025-08-06 | Aggregated |
| TRVITREVI THERAPEUTICS INC | 1 | 2025-05-20 | Aggregated |
| VRCA | 12 | 2025-05-14 | Aggregated |
| ESPRESPERION THERAPEUTICS INC. | 1 | 2025-05-07 | Aggregated |
| CLSDCLEARSIDE BIOMEDICAL INC | 1 | 2025-04-08 | Aggregated |
| PCRXPACIRA BIOSCIENCES INC | 1 | 2025-04-08 | Aggregated |
| HRTXHERON THERAPEUTICS INC | 1 | 2025-02-28 | Aggregated |
| VRCAVERRICA PHARMACEUTICALS INC | 1 | 2024-10-03 | Aggregated |
| RVNCREVANCE THERAPEUTICS INC | 1 | 2024-02-29 | Aggregated |